The International Conference on Novel Psychoactive Substances series, which started in Budapest in 2012, aims to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level. To benefit society and improve lives.
Novel psychoactive substances (NPS) continue to pose challenges to law enforcement authorities, public health officers and policymakers as suppliers continuously adapt to control measures, thus remaining highly dynamic in introducing unpredictable and potentially toxic new substances into the drug market.
This poster, presented during the IX International Conference on NPS(24 to 26 Oct 2022, Panama), showcases some of the work of the EU Early Warning System on new psychoactive substances. Operated by the EMCDDA, in close cooperation with Europol and other partners, it was the first regional early-warning mechanism set up to monitor and
This factsheet summarises information and statistics on new psychoactive substances gathered from recent reports on prevalence, treatment, mortality and legislation in Ireland.
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’ replacements for cannabis, heroin, cocaine, amphetamines, MDMA and benzodiazepines.
In partnership with the Royal College of Psychiatrists, Project NEPTUNE has developed training modules to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.